RecruitingNCT07016035

Translation and Validation of the French mPCOSQ (mPCOSQ-F).

Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.


Sponsor

CHU de Reims

Enrollment

350 participants

Start Date

May 12, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is translating and validating a French version of a quality-of-life questionnaire specifically designed for women with polycystic ovary syndrome (PCOS) — a common hormonal condition — so that French-speaking patients can better communicate how PCOS affects their daily lives. **You may be eligible if...** - You are a woman between 18 and 45 years old - You are fluent in French - You have been diagnosed with PCOS according to current international guidelines (2023) - You are covered by the French social security system **You may NOT be eligible if...** - You have been diagnosed with adrenal hyperplasia, a hormone-producing tumor, Cushing's syndrome, or a thyroid disorder (conditions that can mimic PCOS) - You are pregnant or breastfeeding - You are under legal protection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERmPCOSQ-F and SF-36

Questionnaires


Locations(1)

Damien JOLLY

Reims, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07016035